The acquisition of transiently heritable states in drug‐treated melanoma cells is reminiscent of reversible drug tolerance previously shown to involve chromatin modifications sensitive to HDAC inhibition (Sharma et al, 2010; Ravindran Menon et al, 2015). The gene discussed is HDAC9; the disease is melanoma.